SYNTHESIS-TO-CLINIC Trademark

Trademark Overview

On Friday, November 5, 2021, a trademark application was filed for SYNTHESIS-TO-CLINIC with the United States Patent and Trademark Office. The USPTO has given the SYNTHESIS-TO-CLINIC trademark a serial number of 79336901. The federal status of this trademark filing is REGISTERED as of Tuesday, July 16, 2024. This trademark is owned by Quotient Sciences Ltd. The SYNTHESIS-TO-CLINIC trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Research services relating to the pharmaceutical, biotechnology and nutraceutical industry
synthesis-to-clinic

General Information

Serial Number79336901
Word MarkSYNTHESIS-TO-CLINIC
Filing DateFriday, November 5, 2021
Status700 - REGISTERED
Status DateTuesday, July 16, 2024
Registration Number7445088
Registration DateTuesday, July 16, 2024
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 30, 2024

Trademark Statements

Goods and ServicesResearch services relating to the pharmaceutical, biotechnology and nutraceutical industry

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, April 4, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameQuotient Sciences Ltd
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressGB
Party NameQuotient Sciences Ltd
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressGB
Party NameQuotient Sciences Ltd
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressGB

Trademark Events

Event DateEvent Description
Thursday, March 31, 2022SN ASSIGNED FOR SECT 66A APPL FROM IB
Monday, April 4, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, April 8, 2022APPLICATION FILING RECEIPT MAILED
Wednesday, August 17, 2022ASSIGNED TO EXAMINER
Tuesday, August 23, 2022NON-FINAL ACTION WRITTEN
Wednesday, August 24, 2022NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, September 28, 2022NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
Thursday, September 29, 2022NON-FINAL ACTION WRITTEN
Friday, September 30, 2022NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, December 13, 2022REFUSAL PROCESSED BY MPU
Tuesday, December 13, 2022NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Wednesday, January 4, 2023REFUSAL PROCESSED BY IB
Wednesday, March 1, 2023ASSIGNED TO EXAMINER
Tuesday, June 13, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, June 13, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, June 14, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, August 28, 2023FINAL REFUSAL WRITTEN
Monday, August 28, 2023FINAL REFUSAL E-MAILED
Monday, August 28, 2023NOTIFICATION OF FINAL REFUSAL EMAILED
Wednesday, August 30, 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, August 30, 2023NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Saturday, September 16, 2023NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Tuesday, February 27, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, February 27, 2024TEAS REQUEST FOR RECONSIDERATION RECEIVED
Wednesday, February 28, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, March 25, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 10, 2024NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, April 10, 2024NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, April 10, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, April 29, 2024NOTIFICATION PROCESSED BY IB
Tuesday, April 30, 2024PUBLISHED FOR OPPOSITION
Tuesday, April 30, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 16, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, July 16, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, July 16, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Thursday, October 17, 2024FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Saturday, December 21, 2024FINAL DISPOSITION PROCESSED
Saturday, December 21, 2024FINAL DISPOSITION NOTICE SENT TO IB
Friday, January 10, 2025FINAL DECISION TRANSACTION PROCESSED BY IB

Related Keywords

clinic synthesis nutraceutical industry biotechnology pharmaceutical services relating research